Abstract Small-cell lung cancer (SCLC) is an aggressive cancer characterized by immunosuppressive features leading to poor responses to current immunotherapies. Activation of transposable elements (TE) can trigger an innate immune response. which can synergize with immunotherapeutic protocols in patients. However. https://themightyhobbyers.shop/product-category/book/